C12ORF29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.163200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.071000E-01
Normal-vs-Stage2
6.112400E-01
Normal-vs-Stage3
2.086100E-02
Normal-vs-Stage4
9.520200E-01
Stage1-vs-Stage2
1.825970E-01
Stage1-vs-Stage3
1.702370E-02
Stage1-vs-Stage4
6.695000E-01
Stage2-vs-Stage3
1.289360E-01
Stage2-vs-Stage4
5.180600E-01
Stage3-vs-Stage4
5.948000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.500000E-01
Normal-vs-AfricanAmerican
7.518600E-01
Normal-vs-Asian
1.745800E-01
Caucasian-vs-AfricanAmerican
9.402600E-01
Caucasian-vs-Asian
1.143840E-01
AfricanAmerican-vs-Asian
3.270000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.072400E-01
Normal-vs-Female
6.150800E-01
Male-vs-Female
4.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.478800E-01
Normal-vs-Age(41-60Yrs)
9.504000E-01
Normal-vs-Age(61-80Yrs)
5.723600E-01
Normal-vs-Age(81-100Yrs)
4.988000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.743600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.850800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.779200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.477900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.627400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.301600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.460800E-01
Normal-vs-Daily Drinker
4.980200E-01
Normal-vs-Weekly Drinker
5.084800E-01
Normal-vs-Occasional Drinker
7.662400E-01
Normal-vs-Social Drinker
8.593200E-01
Non Drinker-vs-Daily Drinker
7.296800E-01
Non Drinker-vs-Weekly Drinker
6.163400E-01
Non Drinker-vs-Occasional Drinker
1.935620E-02
Non Drinker-vs-Social Drinker
2.550000E-01
Daily Drinker-vs-Weekly Drinker
8.721000E-01
Daily Drinker-vs-Occasional Drinker
7.338000E-02
Daily Drinker-vs-Social Drinker
4.524800E-01
Weekly Drinker-vs-Occasional Drinker
1.254200E-01
Weekly Drinker-vs-Social Drinker
5.746800E-01
Occasional Drinker-vs-Social Drinker
4.287400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.522400E-01
Normal-vs-Grade 2
7.877400E-01
Normal-vs-Grade 3
8.074000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.092000E-01
Grade 1-vs-Grade 3
3.340400E-01
Grade 1-vs-Grade 4
4.522400E-01
Grade 2-vs-Grade 3
7.279600E-01
Grade 2-vs-Grade 4
7.877400E-01
Grade 3-vs-Grade 4
8.074000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.315200E-01
Normal-vs-NonDiabetic
6.773600E-01
Diabetic-vs-NonDiabetic
4.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.178410E-01
Normal-vs-NoPancreatitis
6.732800E-01
Pancreatitis-vs-NoPancreatitis
8.715800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.326800E-01
Normal-vs-N1
6.454400E-01
N0-vs-N1
4.707600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.298800E-01
Normal-vs-TP53-NonMutant
8.697200E-01
TP53-Mutant-vs-TP53-NonMutant
3.932400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
